APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Coated Coronary Balloon Catheter

Compare research editions
View pricing & licenses

Selected research

Industry Research

Drug Coated Coronary Balloon Catheter Industry Research Report 2026

24 December 2025136 pages

Choose your research edition.

Industry ResearchDrug Coated Coronary Balloon Catheter Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Coated Coronary Balloon Catheter Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Drug Coated Coronary Balloon Catheter Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Coated Coronary Balloon Catheter Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Coated Coronary Balloon Catheter Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Drug Coated Coronary Balloon Catheter market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Drug Coated Coronary Balloon Catheter is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Drug Coated Coronary Balloon Catheter is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Drug Coated Coronary Balloon Catheter is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Drug Coated Coronary Balloon Catheter include B.Braun, BD, Biotronik, Bonston Scientific, Concept Medical Inc, Eurocor Tech GmbH, Medronic, USM Healthcare and Zhejiang Barty Medical Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Drug Coated Coronary Balloon Catheter market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Drug Coated Coronary Balloon Catheter Market by Company

B.Braun

BD

Biotronik

Bonston Scientific

Concept Medical Inc

Eurocor Tech GmbH

Medronic

USM Healthcare

Zhejiang Barty Medical Technology

Blue Sail Medical

Lepu Medical Technology

Yinyi (Liaoning) Biotech

MicroPort

Acotec Scientific

GrandPharma(Cardionovum)

Drug Coated Coronary Balloon Catheter Segment by Type

Sirolimus

Beautiful Moss

Paclitaxel

Others

Drug Coated Coronary Balloon Catheter Segment by Application

Hospital

Clinic

Others

Drug Coated Coronary Balloon Catheter Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Coated Coronary Balloon Catheter market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Coated Coronary Balloon Catheter and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Coated Coronary Balloon Catheter.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Drug Coated Coronary Balloon Catheter manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Drug Coated Coronary Balloon Catheter by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Drug Coated Coronary Balloon Catheter in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Drug Coated Coronary Balloon Catheter Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Drug Coated Coronary Balloon Catheter Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Manufacturers (2021-2026) Table 8. Global Drug Coated Coronary Balloon Catheter Revenue of Manufacturers (2021-2026) Table 9. Global Drug Coated Coronary Balloon Catheter Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Drug Coated Coronary Balloon Catheter Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Drug Coated Coronary Balloon Catheter Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Drug Coated Coronary Balloon Catheter, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Drug Coated Coronary Balloon Catheter, Product Type & Application Table 14. Global Drug Coated Coronary Balloon Catheter Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Drug Coated Coronary Balloon Catheter by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. B.Braun Company Information Table 19. B.Braun Business Overview Table 20. B.Braun Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. B.Braun Drug Coated Coronary Balloon Catheter Product Portfolio Table 22. B.Braun Recent Developments Table 23. BD Company Information Table 24. BD Business Overview Table 25. BD Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. BD Drug Coated Coronary Balloon Catheter Product Portfolio Table 27. BD Recent Developments Table 28. Biotronik Company Information Table 29. Biotronik Business Overview Table 30. Biotronik Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Biotronik Drug Coated Coronary Balloon Catheter Product Portfolio Table 32. Biotronik Recent Developments Table 33. Bonston Scientific Company Information Table 34. Bonston Scientific Business Overview Table 35. Bonston Scientific Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Bonston Scientific Drug Coated Coronary Balloon Catheter Product Portfolio Table 37. Bonston Scientific Recent Developments Table 38. Concept Medical Inc Company Information Table 39. Concept Medical Inc Business Overview Table 40. Concept Medical Inc Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Concept Medical Inc Drug Coated Coronary Balloon Catheter Product Portfolio Table 42. Concept Medical Inc Recent Developments Table 43. Eurocor Tech GmbH Company Information Table 44. Eurocor Tech GmbH Business Overview Table 45. Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Product Portfolio Table 47. Eurocor Tech GmbH Recent Developments Table 48. Medronic Company Information Table 49. Medronic Business Overview Table 50. Medronic Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Medronic Drug Coated Coronary Balloon Catheter Product Portfolio Table 52. Medronic Recent Developments Table 53. USM Healthcare Company Information Table 54. USM Healthcare Business Overview Table 55. USM Healthcare Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. USM Healthcare Drug Coated Coronary Balloon Catheter Product Portfolio Table 57. USM Healthcare Recent Developments Table 58. Zhejiang Barty Medical Technology Company Information Table 59. Zhejiang Barty Medical Technology Business Overview Table 60. Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio Table 62. Zhejiang Barty Medical Technology Recent Developments Table 63. Blue Sail Medical Company Information Table 64. Blue Sail Medical Business Overview Table 65. Blue Sail Medical Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Blue Sail Medical Drug Coated Coronary Balloon Catheter Product Portfolio Table 67. Blue Sail Medical Recent Developments Table 68. Lepu Medical Technology Company Information Table 69. Lepu Medical Technology Business Overview Table 70. Lepu Medical Technology Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Lepu Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio Table 72. Lepu Medical Technology Recent Developments Table 73. Yinyi (Liaoning) Biotech Company Information Table 74. Yinyi (Liaoning) Biotech Business Overview Table 75. Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Product Portfolio Table 77. Yinyi (Liaoning) Biotech Recent Developments Table 78. MicroPort Company Information Table 79. MicroPort Business Overview Table 80. MicroPort Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. MicroPort Drug Coated Coronary Balloon Catheter Product Portfolio Table 82. MicroPort Recent Developments Table 83. Acotec Scientific Company Information Table 84. Acotec Scientific Business Overview Table 85. Acotec Scientific Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Acotec Scientific Drug Coated Coronary Balloon Catheter Product Portfolio Table 87. Acotec Scientific Recent Developments Table 88. GrandPharma(Cardionovum) Company Information Table 89. GrandPharma(Cardionovum) Business Overview Table 90. GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Product Portfolio Table 92. GrandPharma(Cardionovum) Recent Developments Table 93. Global Drug Coated Coronary Balloon Catheter Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Drug Coated Coronary Balloon Catheter Sales by Region (2021-2026) & (K Units) Table 95. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Region (2021-2026) Table 96. Global Drug Coated Coronary Balloon Catheter Sales by Region (2027-2032) & (K Units) Table 97. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Region (2027-2032) Table 98. Global Drug Coated Coronary Balloon Catheter Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Region (2021-2026) Table 100. Global Drug Coated Coronary Balloon Catheter Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Region (2027-2032) Table 102. North America Drug Coated Coronary Balloon Catheter Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Drug Coated Coronary Balloon Catheter Sales by Country (2021-2026) & (K Units) Table 104. North America Drug Coated Coronary Balloon Catheter Sales by Country (2027-2032) & (K Units) Table 105. North America Drug Coated Coronary Balloon Catheter Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Drug Coated Coronary Balloon Catheter Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Drug Coated Coronary Balloon Catheter Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Drug Coated Coronary Balloon Catheter Sales by Country (2021-2026) & (K Units) Table 109. Europe Drug Coated Coronary Balloon Catheter Sales by Country (2027-2032) & (K Units) Table 110. Europe Drug Coated Coronary Balloon Catheter Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Drug Coated Coronary Balloon Catheter Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Drug Coated Coronary Balloon Catheter Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Drug Coated Coronary Balloon Catheter Sales by Country (2021-2026) & (K Units) Table 114. Asia Pacific Drug Coated Coronary Balloon Catheter Sales by Country (2027-2032) & (K Units) Table 115. Asia Pacific Drug Coated Coronary Balloon Catheter Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Drug Coated Coronary Balloon Catheter Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Drug Coated Coronary Balloon Catheter Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Drug Coated Coronary Balloon Catheter Sales by Country (2021-2026) & (K Units) Table 119. South America Drug Coated Coronary Balloon Catheter Sales by Country (2027-2032) & (K Units) Table 120. South America Drug Coated Coronary Balloon Catheter Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Drug Coated Coronary Balloon Catheter Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Drug Coated Coronary Balloon Catheter Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Drug Coated Coronary Balloon Catheter Sales by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Drug Coated Coronary Balloon Catheter Sales by Type (2021-2026) & (K Units) Table 128. Global Drug Coated Coronary Balloon Catheter Sales by Type (2027-2032) & (K Units) Table 129. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Type (2021-2026) Table 130. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Type (2027-2032) Table 131. Global Drug Coated Coronary Balloon Catheter Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Drug Coated Coronary Balloon Catheter Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Type (2021-2026) Table 134. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Type (2027-2032) Table 135. Global Drug Coated Coronary Balloon Catheter Price by Type (2021-2026) & (US$/Unit) Table 136. Global Drug Coated Coronary Balloon Catheter Price by Type (2027-2032) & (US$/Unit) Table 137. Global Drug Coated Coronary Balloon Catheter Sales by Application (2021-2026) & (K Units) Table 138. Global Drug Coated Coronary Balloon Catheter Sales by Application (2027-2032) & (K Units) Table 139. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Application (2021-2026) Table 140. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Application (2027-2032) Table 141. Global Drug Coated Coronary Balloon Catheter Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Drug Coated Coronary Balloon Catheter Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Application (2021-2026) Table 144. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Application (2027-2032) Table 145. Global Drug Coated Coronary Balloon Catheter Price by Application (2021-2026) & (US$/Unit) Table 146. Global Drug Coated Coronary Balloon Catheter Price by Application (2027-2032) & (US$/Unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Drug Coated Coronary Balloon Catheter Distributors List Table 150. Drug Coated Coronary Balloon Catheter Customers List Table 151. Drug Coated Coronary Balloon Catheter Industry Trends Table 152. Drug Coated Coronary Balloon Catheter Industry Drivers Table 153. Drug Coated Coronary Balloon Catheter Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Drug Coated Coronary Balloon Catheter Product Image Figure 5. Global Drug Coated Coronary Balloon Catheter Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Drug Coated Coronary Balloon Catheter Market Size (2021-2032) & (US$ Million) Figure 7. Global Drug Coated Coronary Balloon Catheter Sales (2021-2032) & (K Units) Figure 8. Global Drug Coated Coronary Balloon Catheter Average Price (US$/Unit) & (2021-2032) Figure 9. Sirolimus Product Image Figure 10. Beautiful Moss Product Image Figure 11. Paclitaxel Product Image Figure 12. Others Product Image Figure 13. Hospital Product Image Figure 14. Clinic Product Image Figure 15. Others Product Image Figure 16. Global Drug Coated Coronary Balloon Catheter Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Drug Coated Coronary Balloon Catheter, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Drug Coated Coronary Balloon Catheter Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Drug Coated Coronary Balloon Catheter Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Drug Coated Coronary Balloon Catheter Sales by Region in 2025 Figure 22. Global Drug Coated Coronary Balloon Catheter Revenue by Region in 2025 Figure 23. North America Drug Coated Coronary Balloon Catheter Market Size by Country in 2025 Figure 24. North America Drug Coated Coronary Balloon Catheter Sales Market Share by Country (2021-2032) Figure 25. North America Drug Coated Coronary Balloon Catheter Revenue Market Share by Country (2021-2032) Figure 26. United States Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Drug Coated Coronary Balloon Catheter Market Size by Country in 2025 Figure 30. Europe Drug Coated Coronary Balloon Catheter Sales Market Share by Country (2021-2032) Figure 31. Europe Drug Coated Coronary Balloon Catheter Revenue Market Share by Country (2021-2032) Figure 32. Germany Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Drug Coated Coronary Balloon Catheter Market Size by Country in 2025 Figure 43. Asia Pacific Drug Coated Coronary Balloon Catheter Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Drug Coated Coronary Balloon Catheter Revenue Market Share by Country (2021-2032) Figure 45. China Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Drug Coated Coronary Balloon Catheter Market Size by Country in 2025 Figure 54. South America Drug Coated Coronary Balloon Catheter Sales Market Share by Country (2021-2032) Figure 55. South America Drug Coated Coronary Balloon Catheter Revenue Market Share by Country (2021-2032) Figure 56. Brazil Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Drug Coated Coronary Balloon Catheter Market Size by Country in 2025 Figure 60. Middle East and Africa Drug Coated Coronary Balloon Catheter Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue Market Share by Country (2021-2032) Figure 62. Egypt Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Type (2021-2032) Figure 68. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Type (2021-2032) Figure 69. Global Drug Coated Coronary Balloon Catheter Price (US$/Unit) by Type (2021-2032) Figure 70. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Application (2021-2032) Figure 71. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Application (2021-2032) Figure 72. Global Drug Coated Coronary Balloon Catheter Price (US$/Unit) by Application (2021-2032) Figure 73. Drug Coated Coronary Balloon Catheter Value Chain Figure 74. Drug Coated Coronary Balloon Catheter Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Drug Coated Coronary Balloon Catheter Industry Opportunities and Challenges

Scope & coverage.

Types
  • Sirolimus
  • Beautiful Moss
  • Paclitaxel
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • B.Braun
  • BD
  • Biotronik
  • Bonston Scientific
  • Concept Medical Inc
  • Eurocor Tech GmbH
  • Medronic
  • USM Healthcare
  • Zhejiang Barty Medical Technology
  • Blue Sail Medical
  • Lepu Medical Technology
  • Yinyi (Liaoning) Biotech
  • MicroPort
  • Acotec Scientific
  • GrandPharma(Cardionovum)

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Drug Coated Coronary Balloon Catheter Market Size (2021-2032)
  4. 2.2.2 Global Drug Coated Coronary Balloon Catheter Sales (2021-2032)
  5. 2.2.3 Global Drug Coated Coronary Balloon Catheter Market Average Price (2021-2032)
  6. 2.3 Drug Coated Coronary Balloon Catheter by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Sirolimus
  9. 2.3.3 Beautiful Moss
  10. 2.3.4 Paclitaxel
  11. 2.3.5 Others
  12. 2.4 Drug Coated Coronary Balloon Catheter by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospital
  15. 2.4.3 Clinic
  16. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Drug Coated Coronary Balloon Catheter Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Drug Coated Coronary Balloon Catheter Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Drug Coated Coronary Balloon Catheter Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Drug Coated Coronary Balloon Catheter Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Drug Coated Coronary Balloon Catheter Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Drug Coated Coronary Balloon Catheter, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Drug Coated Coronary Balloon Catheter, Product Type & Application
  8. 3.8 Global Manufacturers of Drug Coated Coronary Balloon Catheter, Established Date
  9. 3.9 Global Drug Coated Coronary Balloon Catheter Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 B.Braun
  2. 4.1.1 B.Braun Company Information
  3. 4.1.2 B.Braun Business Overview
  4. 4.1.3 B.Braun Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 B.Braun Drug Coated Coronary Balloon Catheter Product Portfolio
  6. 4.1.5 B.Braun Recent Developments
  7. 4.2 BD
  8. 4.2.1 BD Company Information
  9. 4.2.2 BD Business Overview
  10. 4.2.3 BD Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 BD Drug Coated Coronary Balloon Catheter Product Portfolio
  12. 4.2.5 BD Recent Developments
  13. 4.3 Biotronik
  14. 4.3.1 Biotronik Company Information
  15. 4.3.2 Biotronik Business Overview
  16. 4.3.3 Biotronik Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Biotronik Drug Coated Coronary Balloon Catheter Product Portfolio
  18. 4.3.5 Biotronik Recent Developments
  19. 4.4 Bonston Scientific
  20. 4.4.1 Bonston Scientific Company Information
  21. 4.4.2 Bonston Scientific Business Overview
  22. 4.4.3 Bonston Scientific Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Bonston Scientific Drug Coated Coronary Balloon Catheter Product Portfolio
  24. 4.4.5 Bonston Scientific Recent Developments
  25. 4.5 Concept Medical Inc
  26. 4.5.1 Concept Medical Inc Company Information
  27. 4.5.2 Concept Medical Inc Business Overview
  28. 4.5.3 Concept Medical Inc Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Concept Medical Inc Drug Coated Coronary Balloon Catheter Product Portfolio
  30. 4.5.5 Concept Medical Inc Recent Developments
  31. 4.6 Eurocor Tech GmbH
  32. 4.6.1 Eurocor Tech GmbH Company Information
  33. 4.6.2 Eurocor Tech GmbH Business Overview
  34. 4.6.3 Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Product Portfolio
  36. 4.6.5 Eurocor Tech GmbH Recent Developments
  37. 4.7 Medronic
  38. 4.7.1 Medronic Company Information
  39. 4.7.2 Medronic Business Overview
  40. 4.7.3 Medronic Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Medronic Drug Coated Coronary Balloon Catheter Product Portfolio
  42. 4.7.5 Medronic Recent Developments
  43. 4.8 USM Healthcare
  44. 4.8.1 USM Healthcare Company Information
  45. 4.8.2 USM Healthcare Business Overview
  46. 4.8.3 USM Healthcare Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 USM Healthcare Drug Coated Coronary Balloon Catheter Product Portfolio
  48. 4.8.5 USM Healthcare Recent Developments
  49. 4.9 Zhejiang Barty Medical Technology
  50. 4.9.1 Zhejiang Barty Medical Technology Company Information
  51. 4.9.2 Zhejiang Barty Medical Technology Business Overview
  52. 4.9.3 Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio
  54. 4.9.5 Zhejiang Barty Medical Technology Recent Developments
  55. 4.10 Blue Sail Medical
  56. 4.10.1 Blue Sail Medical Company Information
  57. 4.10.2 Blue Sail Medical Business Overview
  58. 4.10.3 Blue Sail Medical Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Blue Sail Medical Drug Coated Coronary Balloon Catheter Product Portfolio
  60. 4.10.5 Blue Sail Medical Recent Developments
  61. 4.11 Lepu Medical Technology
  62. 4.11.1 Lepu Medical Technology Company Information
  63. 4.11.2 Lepu Medical Technology Business Overview
  64. 4.11.3 Lepu Medical Technology Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Lepu Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio
  66. 4.11.5 Lepu Medical Technology Recent Developments
  67. 4.12 Yinyi (Liaoning) Biotech
  68. 4.12.1 Yinyi (Liaoning) Biotech Company Information
  69. 4.12.2 Yinyi (Liaoning) Biotech Business Overview
  70. 4.12.3 Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Product Portfolio
  72. 4.12.5 Yinyi (Liaoning) Biotech Recent Developments
  73. 4.13 MicroPort
  74. 4.13.1 MicroPort Company Information
  75. 4.13.2 MicroPort Business Overview
  76. 4.13.3 MicroPort Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 MicroPort Drug Coated Coronary Balloon Catheter Product Portfolio
  78. 4.13.5 MicroPort Recent Developments
  79. 4.14 Acotec Scientific
  80. 4.14.1 Acotec Scientific Company Information
  81. 4.14.2 Acotec Scientific Business Overview
  82. 4.14.3 Acotec Scientific Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Acotec Scientific Drug Coated Coronary Balloon Catheter Product Portfolio
  84. 4.14.5 Acotec Scientific Recent Developments
  85. 4.15 GrandPharma(Cardionovum)
  86. 4.15.1 GrandPharma(Cardionovum) Company Information
  87. 4.15.2 GrandPharma(Cardionovum) Business Overview
  88. 4.15.3 GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Product Portfolio
  90. 4.15.5 GrandPharma(Cardionovum) Recent Developments
5 Global Drug Coated Coronary Balloon Catheter Market Scenario by Region
  1. 5.1 Global Drug Coated Coronary Balloon Catheter Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Drug Coated Coronary Balloon Catheter Sales by Region: 2021-2032
  3. 5.2.1 Global Drug Coated Coronary Balloon Catheter Sales by Region: 2021-2026
  4. 5.2.2 Global Drug Coated Coronary Balloon Catheter Sales by Region: 2027-2032
  5. 5.3 Global Drug Coated Coronary Balloon Catheter Revenue by Region: 2021-2032
  6. 5.3.1 Global Drug Coated Coronary Balloon Catheter Revenue by Region: 2021-2026
  7. 5.3.2 Global Drug Coated Coronary Balloon Catheter Revenue by Region: 2027-2032
  8. 5.4 North America Drug Coated Coronary Balloon Catheter Market Facts & Figures by Country
  9. 5.4.1 North America Drug Coated Coronary Balloon Catheter Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Drug Coated Coronary Balloon Catheter Sales by Country (2021-2032)
  11. 5.4.3 North America Drug Coated Coronary Balloon Catheter Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Drug Coated Coronary Balloon Catheter Market Facts & Figures by Country
  16. 5.5.1 Europe Drug Coated Coronary Balloon Catheter Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Drug Coated Coronary Balloon Catheter Sales by Country (2021-2032)
  18. 5.5.3 Europe Drug Coated Coronary Balloon Catheter Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Drug Coated Coronary Balloon Catheter Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Drug Coated Coronary Balloon Catheter Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Drug Coated Coronary Balloon Catheter Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Drug Coated Coronary Balloon Catheter Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Drug Coated Coronary Balloon Catheter Market Facts & Figures by Country
  41. 5.7.1 South America Drug Coated Coronary Balloon Catheter Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Drug Coated Coronary Balloon Catheter Sales by Country (2021-2032)
  43. 5.7.3 South America Drug Coated Coronary Balloon Catheter Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Drug Coated Coronary Balloon Catheter Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Drug Coated Coronary Balloon Catheter Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Drug Coated Coronary Balloon Catheter Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Drug Coated Coronary Balloon Catheter Sales by Type (2021-2032)
  2. 6.1.1 Global Drug Coated Coronary Balloon Catheter Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Drug Coated Coronary Balloon Catheter Sales Market Share by Type (2021-2032)
  4. 6.2 Global Drug Coated Coronary Balloon Catheter Revenue by Type (2021-2032)
  5. 6.2.1 Global Drug Coated Coronary Balloon Catheter Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Drug Coated Coronary Balloon Catheter Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Drug Coated Coronary Balloon Catheter Sales by Application (2021-2032)
  2. 7.1.1 Global Drug Coated Coronary Balloon Catheter Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Drug Coated Coronary Balloon Catheter Sales Market Share by Application (2021-2032)
  4. 7.2 Global Drug Coated Coronary Balloon Catheter Revenue by Application (2021-2032)
  5. 7.2.1 Global Drug Coated Coronary Balloon Catheter Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Drug Coated Coronary Balloon Catheter Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Drug Coated Coronary Balloon Catheter Value Chain Analysis
  2. 8.1.1 Drug Coated Coronary Balloon Catheter Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Drug Coated Coronary Balloon Catheter Production Mode & Process
  5. 8.2 Drug Coated Coronary Balloon Catheter Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Drug Coated Coronary Balloon Catheter Distributors
  8. 8.2.3 Drug Coated Coronary Balloon Catheter Customers
9 Global Drug Coated Coronary Balloon Catheter Analyzing Market Dynamics
  1. 9.1 Drug Coated Coronary Balloon Catheter Industry Trends
  2. 9.2 Drug Coated Coronary Balloon Catheter Industry Drivers
  3. 9.3 Drug Coated Coronary Balloon Catheter Industry Opportunities and Challenges
  4. 9.4 Drug Coated Coronary Balloon Catheter Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst